The One Health Trust at UNGA Week 2024

For the 2024 Lancet series on AMR, OHT brought together leading experts to address the growing global AMR burden. The 2024 United Nations General Assembly High-Level Meeting on AMR offers a chance to ignite action worldwide, offering solutions and global targets ahead of the event.

In Global Health Action, an OHT co-authored study explores barriers to implementing environmental surveillance of antibiotic resistance in low- and middle-income countries.

Collaborative OHT research in Science Translational Medicine outlines a strategy for harnessing the full potential of vaccines to promote healthy aging for a rapidly aging global population.

In npj Aging, an OHT-co-authored article highlights the projected skyrocketing costs of care for Alzheimer’s disease and related dementias in the United States.

Out in The Lancet Regional Health – Southeast Asia, an OHT co-authored article outlines the progress made in 11 World Health Organization South-East Asia region member states in mitigating drug resistance.

In The Lancet series on ‘Antimicrobial Resistance: The need for sustainable access to effective antibiotics,’ the authors, convened by OHT’s Dr. Ramanan Laxminarayan, propose achievable targets of 10-20-30 by 2030 to tackle the AMR issue.

OHT and other MAAP collaborators released the results of a 4-year study of antimicrobial resistance data made available by 14 participating African countries.